首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   189篇
  免费   12篇
  国内免费   5篇
儿科学   14篇
基础医学   16篇
口腔科学   2篇
临床医学   32篇
内科学   46篇
皮肤病学   2篇
神经病学   3篇
特种医学   19篇
外科学   28篇
综合类   2篇
预防医学   10篇
眼科学   4篇
药学   19篇
肿瘤学   9篇
  2021年   7篇
  2020年   5篇
  2019年   2篇
  2018年   4篇
  2017年   5篇
  2016年   5篇
  2015年   3篇
  2014年   8篇
  2013年   12篇
  2011年   3篇
  2010年   8篇
  2009年   2篇
  2008年   10篇
  2007年   11篇
  2006年   4篇
  2005年   5篇
  2004年   4篇
  2003年   1篇
  2002年   3篇
  2001年   3篇
  2000年   2篇
  1999年   6篇
  1998年   10篇
  1997年   5篇
  1996年   12篇
  1995年   5篇
  1994年   2篇
  1993年   10篇
  1992年   4篇
  1991年   2篇
  1990年   1篇
  1989年   7篇
  1988年   1篇
  1987年   3篇
  1985年   3篇
  1984年   1篇
  1983年   5篇
  1982年   2篇
  1981年   1篇
  1980年   3篇
  1978年   1篇
  1976年   2篇
  1975年   1篇
  1974年   3篇
  1970年   1篇
  1962年   1篇
  1961年   1篇
  1958年   1篇
  1956年   3篇
  1955年   1篇
排序方式: 共有206条查询结果,搜索用时 15 毫秒
21.
In randomized controlled trials (RCTs), sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors have been shown to confer glycaemic and extra‐glycaemic benefits. The DARWIN‐T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes) study was a multicentre retrospective study designed to evaluate the baseline characteristics of patients receiving dapagliflozin vs those receiving selected comparators (dipeptidyl peptidase‐4 inhibitors, gliclazide, or glucagon‐like peptide‐1 receptor agonists), and drug effectiveness in routine clinical practice. From a population of 281 217, the analysis included 17 285 patients initiating dapagliflozin or comparator glucose‐lowering medications (GLMs), 6751 of whom had a follow‐up examination. At baseline, participants starting dapagliflozin were younger, had a longer disease duration, higher glycated haemoglobin (HbA1c) concentration, and a more complex history of previous GLM use, but the clinical profile of patients receiving dapagliflozin changed during the study period. Dapagliflozin reduced HbA1c by 0.7%, body weight by 2.7 kg, and systolic blood pressure by 3.0 mm Hg. Effects of comparator GLMs were also within the expected range, based on RCTs. This real‐world study shows an initial channelling of dapagliflozin to difficult‐to‐treat patients. Nonetheless, dapagliflozin provided significant benefits with regard to glucose control, body weight and blood pressure that were in line with findings from RCTs.  相似文献   
22.
23.
The between-run accuracy and reproducibility of vapor-alcohol control tests associated with quantitative evidential breath-alcohol testing in the field were evaluated. Control samples were generated at six separate sites with 34 degrees C TOXITEST II breath-alcohol simulators and analyzed by infrared spectrometry with Model 5000-D intoxilyzers in the recirculation mode. Control test results at target alcohol concentrations of 0.060, 0.080, 0.090, 0.100, 0.110, and 0.120 g/210 L (n = 779) were combined and analyzed by standard statistical methods. Results were correlated with target values, and the signed and absolute differences were calculated and analyzed. Data treatment included ANOVA, linear regression analysis, t statistics, and relative and cumulative frequency distributions of the differences. We found the performance of these current generation simulators in the field to be similarly satisfactory to that obtained in our laboratory evaluation. We further found that vapor-alcohol control samples generated with these devices conformed to established formal requirements and that they can serve as an effective quality assurance measure in evidential breath-alcohol analysis.  相似文献   
24.
25.

OBJECTIVE

To examine factors associated with clinical microalbuminuria (MA) diagnosis in children and adolescents in the T1D Exchange clinic registry.

RESEARCH DESIGN AND METHODS

T1D Exchange participants <20 years of age with type 1 diabetes ≥1 year and urinary albumin-to-creatinine ratio (ACR) measured within the prior 2 years were included in the analysis. MA diagnosis required all of the following: 1) a clinical diagnosis of sustained MA or macroalbuminuria, 2) confirmation of MA diagnosis by either the most recent ACR being ≥30 mg/g or current treatment with an ACE inhibitor (ACEI) or angiotensin receptor blocker (ARB), and 3) no known cause for nephropathy other than diabetes. Logistic regression was used to assess factors associated with MA.

RESULTS

MA was present in 329 of 7,549 (4.4%) participants, with a higher frequency associated with longer diabetes duration, higher mean glycosylated hemoglobin (HbA1c) level, older age, female sex, higher diastolic blood pressure (BP), and lower BMI (P ≤ 0.01 for each in multivariate analysis). Older age was most strongly associated with MA among participants with HbA1c ≥9.5% (≥80 mmol/mol). MA was uncommon (<2%) among participants with HbA1c <7.5% (<58 mmol/mol). Of those with MA, only 36% were receiving ACEI/ARB treatment.

CONCLUSIONS

Our results emphasize the importance of good glycemic and BP control, particularly as diabetes duration increases, in order to reduce the risk of nephropathy. Since age and diabetes duration are important nonmodifiable factors associated with MA, the importance of routine screening is underscored to ensure early diagnosis and timely treatment of MA.Elevated urinary albumin excretion is an early sign of diabetic kidney disease (DKD). The American Diabetes Association (ADA) recommends screening for microalbuminuria (MA) annually in people with type 1 diabetes after 10 years of age and 5 years of diabetes duration, with a diagnosis of MA requiring two of three tests to be abnormal (1). Early diagnosis of MA is important because effective treatments exist to limit the progression of DKD (1). However, although reduced rates of MA have been reported over the past few decades in some (24) but not all (5,6) studies, it has been suggested that the development of proteinuria has not been prevented but, rather, has been delayed by ∼10 years and that further improvements in care are needed (7).Limited data exist on the frequency of a clinical diagnosis of MA in the pediatric population with type 1 diabetes in the U.S. Our aim was to use the data from the T1D Exchange clinic registry to assess factors associated with MA in 7,549 children and adolescents with type 1 diabetes.  相似文献   
26.
27.
28.
As cardiac transplantation has become widely available, computed tomography (CT) of the chest has played a useful role in the examination of patients after heart transplantation. To determine anatomic features related to the procedure, the authors evaluated 59 scans in 46 patients who had undergone orthotopic cardiac transplantation. Aortic anastomosis (seen in 98% of scans) and altered spacing between the great vessels (83%) proved to be the most common and most reliable findings. Other features including atrial anastomosis, high main pulmonary artery segment, remnant superior vena cava, and cardiac reorientation were also seen. Accurate interpretation of adenopathy, mediastinal abscess, and pericardial effusion will be enhanced in these patients through a better understanding of the cardiovascular-pericardial complex, which is afforded by CT.  相似文献   
29.
30.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号